does tirzepatide affect liver enzymes Frontiers Can tirzepatide (glucagon-like peptide-1 receptor

Rybelsus is a glucagon-like peptide-1 (GLP-1) receptor agonist licensed in the UK specifically for type 2 diabetes management, not for weight management (though weight loss is often observed as a secondary effect)

Eli Lilly has submitted it for approval in more than 40 countries, the UK among them, but no MHRA timeline has been confirmed

It has various weight loss benefits, such as improving insulin sensitivity, reducing inflammation, and promoting healthy hormone balance

Not only are those users reducing their caloric intake, but there is also growing evidence that GLP-1 users develop a preference for nutrient-rich, higher-protein foods